Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis
Titel:
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis
Auteur:
Orefice, Nicola S. Alhouayek, Mireille Carotenuto, Antonio Montella, Silvana Barbato, Franscesco Comelli, Albert Calignano, Antonio Muccioli, Giulio G. Orefice, Giuseppe